Ex Parte Song et al - Page 6

                Appeal 2006-2175                                                                             
                Application 10/122,855                                                                       
                Final Office Action 7-8, mailed April 16, 2004).  Specifically, the Examiner                 
                stated that Severson, Jr. fails to “teach that the amylase does not comprise                 
                TERMAMYL as recited in the instant claims” (Non-Final Office Action 8,                       
                mailed April 16, 2004).  However, the Examiner concluded that it would                       
                have been obvious to one of ordinary skill in the art “to formulate a liquid                 
                detergent composition comprising an alpha amylase enzyme that is not                         
                TERMAMYL because Severson, Jr. teach[es] the equivalence of                                  
                TERMAMYL with other amylases” (Non-Final Office Action 8, mailed                             
                April 16, 2004).  As further motivation for the proposed selection of the                    
                amylase enzyme, the Examiner found that Severson, Jr. teaches that “various                  
                amylases can be utilized in the liquid detergent composition and furthermore                 
                teaches a method to stabilize enzymes using boric acid and propylene                         
                glycol” (Non-Final Office Action 8-9, mailed April 16, 2004).                                
                      Regarding claims 1, 8, and 13, Appellants argue that Severson, Jr.                     
                does not disclose excluding Termamyl from his detergent (Br. 20).  Rather,                   
                Appellants argue, Severson, Jr.’s disclosure of the “equivalence among                       
                amylase enzymes provides no suggestion or motivation for improvement in                      
                stability by excluding Termamyl alpha amylase enzyme” (Br. 20).                              
                Appellants further argue that the unexpected result of improved enzyme                       
                stability is clearly demonstrated by the data in Tables 1 and 2 on page 5 of                 
                their Specification such that any prima facie case of obviousness established                
                by the Examiner has been “rebutted by evidence of unexpected results” (Br.                   
                21).                                                                                         
                      Citing In re Mills, 16 USPQ2d 1430 (Fed. Cir. 1990), Appellants                        
                contend that simply because the prior art could be modified to arrive at the                 
                claimed invention would not have made the modification obvious unless the                    

                                                     6                                                       

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next

Last modified: September 9, 2013